Before you can access ASH's online program, you must agree to the following:
Last updated January 16, 2009. Please note that this site represents the latest program changes
and differs from the print version in some details.

Basic Science and Clinical Practice in Blood Transfusion Poster III

Monday, December 8, 2008: 5:30 PM-7:30 PM
Hall A (Moscone Center)
The Emerging Role of RH Genotyping in Chronically Transfused Sickle Cell Disease Patients

Ross Fasano, MD1*, Alessandro Monaco, PhD2*, Emily Riehm Meier, MD1*, John Otridge, PhD3*, Hallie Lee-Stroka, MT(ASCP)SBB4*, Philippe Pary, MT(ASCP)SBB5*, Harvey G. Klein, MD4, Francesco M. Marincola, MD2*, Naomi L.C. Luban, MD6 and David Stroncek, MD4*

1Hematology/Oncology, Children's National Medical Center, Washington, DC
2Transfusion Medicine-Immunogenetics, National Institutes of Health, Bethesda, MD
3Progenika Inc, Cambridge, MA
4Transfusion Medicine, National Institutes of Health, Bethesda, MD
5Transfusion Medicine, Children's National Medical Center, Washington, DC
6Transfusion Medicine, Hematology/Oncology, Children's National Medical Center, Washington, DC

Fatal Disseminated Intravascular Coagulation and Autoimmune Hemolytic Anemia Due to Anti-Ena

Ellen B Klapper, M.D.1*, Joanna J Xie, M.D.1*, George Garratty, PhD2, Samuel Pepkowitz, M.D.1* and Patricia Arndt2*

1Pathology, Cedars Sinai Medical Center, Los Angeles, CA
2Southern California Region, American Red Cross Blood Svcs., Pomona, CA

Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease Patients : Evidence of An Emerging Syndrome with Suicidal Erythrocyte Death

France Noizat-Pirenne, MD, PhD1*, Philippe Chadebech, PhD1*, Anoosha Habibi, MD2*, Dora Bachir, MD2*, Ruben Nzouakou, MD2*, Frederic Galacteros, MD, PhD2* and Philippe Bierling, MD, PhD1*

1Etablissement Français du Sang, Hôpital Henri Mondor, Créteil, France
2Sickle Cell Disease Center, Hôpital Henri Mondor, Créteil, France

Mapping Alloreactive T-Helper Cell Epitopes on the K1 (Kell) Blood Group Antigen

Jillian Stephen, BSc1*, Robert N Barker, BSc, PhD2* and Stanislaw J Urbaniak, MBChB, PhD, FRCP, FRCPath3

1Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, United Kingdom
2Department of Medicine & Therapeutics, University of Aberdeen, Aberdeen, United Kingdom
3Department of Medicine and Therapeutics, Academic Transfusion Medicine Unit, Aberdeen, United Kingdom

The Organization of the National Blood Bank for Rare Blood Units in France

Anne Fialaire-Legendre, Pharm, D, PhD1*, Btissam Chami, Pharm, D, PhD1*, Thierry Peyrard, Pharm, D2*, Pierre-Yves Le Pennec, MD2*, Philippe Bierling, MD, PhD1* and France Noizat-Pirenne, MD, PhD1*

1Etablissement Français du Sang, Hôpital Henri Mondor, Créteil, France
2Cnrgs, Institut National de la Transfusion Sanguine, Paris, France

Mapping of Helper Epitopes to HPA-1a in Neonatal Alloimmune Thrombocytopenia with T-Cell Clones

Rachel Rayment, MBChB, DPhil1*, Nick Willcox, MD, PhD2*, David Roberts, MD, PhD3*, Wendy J Pickford, BSc, PhD4*, Rosa Faner-Canet5*, Manel Juan, MD6*, Robert N Barker, BSc, PhD4* and Stanislaw J Urbaniak, MBChB, PhD, FRCP, FRCPath7

1Arthur Bloom Haemophilia Centre, University Hospital of Wales, Cardiff, United Kingdom
2Clinical Neurology, University of Oxford, Oxford, United Kingdom
3John Radcliffe Hospital, National Blood Service, Oxford, United Kingdom
4Department of Medicine & Therapeutics, University of Aberdeen, Aberdeen, United Kingdom
5Igtp, LIRAD-BST, Badalona, Spain
6Immunology Service, CDB, Barcelona 08036
7Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, United Kingdom

Hematologic Findings and Transfusion Therapy in Severe Pediatric Plasmodium Falciparum Malaria:  Results from a Prospective Observational Study in Uganda

Christine Cserti-Gazdewich, MD1, Aggrey Dhabangi, MBChB2*, Charles Musoke, MBChB2*, Nicolette Nabukeera-Barungi, MBChB, MMEd2*, Henry Ddungu, MBChB, MMEd2*, Arthur Mpimbaza, MBChB, MMEd2*, Isaac Ssewanyana, BSc3* and Walter H. Dzik, MD4

1Blood Transfusion Med., 3EC-306, Toronto General Hospital, Toronto, ON, Canada
2Paediatrics, Mulago Hospital, Kampala, Uganda
3Flow Cytometry, Joint Clinical Research Centre, Kampala, Uganda
4Massachusetts General Hospital, Boston, MA

Antibody Development in Pediatric Sickle Cell Patients Undergoing Erythrocytapheresis: A 10 Year Review

William B Lockwood, PhD, MD1*, Gwendolyn J Godfrey, DO, MPH1*, Salvatore Bertolone, MD2 and Ashok Raj, MD2*

1Department of Pathology and Laboratory Medicine, University of Louisville, Louisville, KY
2Pediatrics, Division of Pediatric Hematology/Oncology, University of Louisville, Louisville, KY

Efficacy and Cost-Effectiveness of a Limited Phenotype Matching Transfusion Protocol for Children with Sickle Cell Disease

Jerry E Squires, MD, PhD1*, Vinu Jyothi, MBBS2*, Sherron M. Jackson, MD2*, Miguel Abboud, MD3* and Ram Kalpatthi, MD2

1Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC
2Pediatric Hematology Oncology, Medical University of South Carolina, Charleston, SC
3Children's Cancer Center of Lebanon, Beirut, Lebanon

Novel Antimicrobial Peptide-Based Blood Safety Strategies for Bacterial Reduction

Ketha V. K. Mohan, Ph.D.*, Shilpakala Sainath Rao, Ph., D.* and Chintamani D Atreya, Ph.D.*

Division of Hematology, Center for Biologics Evaluation & Research, F.D.A., Bethesda, MD

The True Cost of Red Blood Cell Transfusion in Surgical Patients

Aryeh Shander, MD1*, Axel Hofmann, ME2*, Sherri Ozawa, RN3* and Mazyar Javidroozi, MD1*

1Anesthesiology, Critical Care and Hyperbaric Medicine, Englewood Hospital & Medical Center, Englewood, NJ
2Medical Society for Blood Management, Laxenburg, Austria
3The New Jersey Institute for Bloodless Medicine and Surgery, Englewood Hospital and Medical Center, Englewood, NJ

A Novel Intravenous Catheter with Self-Operating Pretransfusion Blood Sampling for Enhanced Transfusion Safety: Retrospective Risk Analysis and Prospective Phase II Trial in Emergency Care

Michael Notter, MD1*, Ariane Storch1*, Ellen Richter-Loeseke, BSc2*, Hans-Richard Arntz, MD3*, Johannes Fakler, MD4*, Eckhard Thiel, MD, PhD5, Ephrath Lahmer-Naim, PhD6*, Adolf Pfaff7* and Jan Breckwoldt, MD8*

1Hematology and Oncology, Charité-Campus Benjamin Franklin, Berlin, Germany
2Cardiac Surgery, Charité-Campus Mitte, Berlin, Germany
3Cardiology, Charité-Campus Benjamin Franklin, Berlin, Germany
4Trauma Surgery, Charité-Campus Benjamin Franklin, Berlin, Germany
5Hematology and Oncology, Charite Campus Benjamin Franklin, Berlin, Germany
6Coordination of Clinical Studies, Charité - Campus Rudolf Virchow, Berlin, Germany
7Pfaff GmbH, Waldkirch, Germany
8Anaesthesiology, Charité-Campus Benjamin Franklin, Berlin, Germany

Red Cell Transfusion Support for Hematology and Oncology Patients Is Both Substantial and Often Required Urgently. Results from the Bloodhound Study: A Comprehensive, Prospective Australian Study of Red Cell Use

Jake Shortt1, Neil Waters1*, Mary Comande1*, Mark N Polizzotto1*, Martine Moran1*, Marija Borosak1*, Damien J Jolley2* and Erica M Wood1*

1Transfusion Medicine Service, Australian Red Cross Blood Service, Melbourne, Australia
2Centre for Research Excellence in Patient Safety, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia

*signifies non-member of ASH